1)Bayés de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989; 117: 151-9
|
|
|
2)Daubert JP, Zareba W, Cannom DS, et al. MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008; 51: 1357-65
|
|
|
3)Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008; 359: 1009-17
|
|
|
4)Hisamatsu T, Ohkubo T, Miura K, et al; NIPPON DATA90 Reserch Group. Association between J-point elevation and death from coronary artery disease--15-year follow up of the NIPPON DATA90. Circ J. 2013; 77: 1260-6
|
|
|
5)Naruse Y, Tada H, Harimura Y, et al. Early repolarization increases the occurrence of sustained ventricular tachyarrhythmias and sudden death in the chronic phase of an acute myocardial infarction. Circ Arrhythm Electrophysiol. 2014; 7: 626-32
|
|
|
6)Bigger JT Jr, Whang W, Rottman JN, et al. Mechanisms of death in the cabg patch trial: A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation. 1999; 99: 1416-21
|
|
|
7)Chow T, Kereiakes DJ, Onufer J, MASTER Trial Investigators. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol. 2008; 52: 1607-15
|
|
|
8)Ikeda T, Yoshino H, Sugi K, et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study. J Am Coll Cardiol. 2006; 48: 2268-74
|
|
|
9)Koruth JS, Dukkipati S, Miller MA, et al. Bipolar irrigated radiofrequency ablation: A therapeutic option for refractory intramural atrial and ventricular tachycardia circuits. Heart Rhythm. 2012; 9: 1932-41
|
|
|
10)Miwa Y, Ikeda T, Mera H, et al. Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J. 2010; 74: 856-63
|
|
|
11)Chung MK, Szymkiewicz SJ, Shao M, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010; 56: 194-203
|
|
|
12)Eggen MD, Bonner MD, Williams ER, et al. Multimodal imaging of a transcatheter pacemaker implantation within a reanimated human heart. Heart Rhythm. 2014; 11: 2331-2
|
|
|